NIH-funded research R01 grant

Molecular control of blood pressure by progranulin in blood vessel cells

Official title: Molecular mechanisms of progranulin as a regulator of endothelial biology and blood pressure control

Funded at University of South Alabama · NIH-11321252 · Data updated 2026-11-12

A study to understand how progranulin helps blood vessels stay healthy and keep blood pressure normal, with insights that could lead to new treatments for hypertension.

More Blood Pressure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of South Alabama
NIH-funded
Lab location1 site (Mobile, United States)
Project startSeptember 3, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$463,961
NIH project number5R01HL169202-03
Project IDNIH-11321252 on NIH RePORTER

Who could benefit from this research

Could help

Adults with high blood pressure or cardiovascular risk factors, or individuals with endothelial dysfunction may benefit from future translational advances.

Less likely to help

People without hypertension or endothelial dysfunction may not directly benefit from this research.

What this research studies

This project looks at how a protein called progranulin affects endothelial cells that line our blood vessels and how this impacts blood pressure. The researchers will investigate how ACE and AMPK pathways interact with progranulin to regulate vascular function, using models that mimic human cardiovascular biology. By exploring how endothelial progranulin deficiency leads to hypertension, they hope to uncover new targets to restore vessel health and control blood pressure. The work builds on prior findings that restoring progranulin can improve vascular function and blood pressure in animal studies.

Why it matters

Potential benefit: If successful, the work could reveal new strategies to prevent or treat hypertension by boosting progranulin pathways in blood vessels.

How similar studies have gone: Previous studies showed that boosting progranulin can improve vascular function and reduce hypertension in models, supporting this approach.

Where this research is happening

  • University of South Alabama
    Mobile, United States
    Active

Researchers

  • Principal investigator: Bruder, Thiago — University of South Alabama
  • Study coordinator: Bruder, Thiago

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.